Objective SLE is a systemic autoimmune disease in which the complement system plays a key pathogenic role, yet the ...
Omeros Corporation (NASDAQ:OMER) Q4 2025 Earnings Call Transcript April 1, 2026 Operator: Good afternoon, and welcome to today’s earnings call for Omeros Corporation. [Operator Instructions] Please be ...
Q4 2025 Earnings Call March 31, 2026 4:30 PM EDTCompany ParticipantsGregory Demopulos - Co-Founder, Chairman, CEO ...
Detailed price information for Dianthus Therapeutics Inc (DNTH-Q) from The Globe and Mail including charting and trades.
Omeros, a biopharmaceutical company, marked a significant milestone in its fourth quarter of 2025 with two major successes ...
Researchers show that pharmacological activation of hypoxia signaling improves metabolism, limits fat accumulation, and restores bone health in obese mice Obesity is widely known for increasing the ...
A research team from the Johns Hopkins Kimmel Cancer Center, its Bloomberg~Kimmel Institute for Cancer Immunotherapy and the ...
BACKGROUND: Despite antiplatelet therapy, some patients remain at high ischemic risk because of drug nonresponsiveness or high residual platelet reactivity). We aimed to target an orphan platelet GPCR ...
HIV infection is a chronic condition currently characterized by effective suppression of circulating virus under efficient antiretroviral therapy with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results